
Lung Cancer Considered
Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda
317 episodes • 0 archived •
Virtual Tumor Board: Resectable EGFR NSCLC
July 1
July 1
39 mins
FDA Approval: Taletrectinib and ROS1 NSCLC
June 24
June 24
29 mins
IASLC - ASCO 2025 Highlights
June 6
June 6
55 mins
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC
May 27
May 27
33 mins
LCC in Korean: Lung Cancer Updates & Future Directions
May 23
May 23
33 mins
Global Advances and Persistent Disparities in Lung Cancer Treatment
May 20
May 20
47 mins
Dr. Bryant Lin Teaching My Cancer
May 6
May 6
41 mins
AACR 2025 Highlights
May 2
May 2
52 mins
What You Should Know About RET-Positive NSCLC: Live from TexasLung25
April 29
April 29
30 mins
Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
April 22
April 22
40 mins